The collaboration will play to Birmingham’s strengths in healthcare data and digitalisation of health care services.
News
Boehringer to launch first reusable soft mist inhaler
Pharmacists are likely to see people with COPD and asthma more regularly than a GP or nurse, so they play a pivotal role in educating patients on their medicines and inhaler technique.
Santen’s Ikervis effective for dry eye
The treatment proved effectiveness, tolerability and safety in the PERSPECTIVE trial.
Age ‘shouldn’t be a barrier’ in adopting tech in NHS
In 2019, 91% of adults in the UK are recent internet users, but just 47% of adults aged 75 years and over are.
A&E attendances twice as high in deprived areas
Attendances for the 20% of the population living in the most deprived areas also account for 27% of all A&E attendances.
Novartis’ MS drug trumps Sanofi’s Aubagio
The drug was able to reduce annualised MS relapse rates by 50.5% and 58.5% in the ASCLEPIOS I and II trials.
Medtronic, Novo Nordisk enter digital diabetes solutions deal
The new collaboration will develop solutions to integrate insulin dosing data from future Novo Nordisk smart insulin pens into Continuous Glucose Monitoring devices from Medtronic.
ICR discovers major biological processes in myeloma development
The discovery could aid the development of more personalised treatments for myeloma patients.
NICE, PHE publish antimicrobial prescribing guidance on pneumonia
New recommendations have been added to highlight that antibiotic treatment should be started as soon as possible – no more than four hours after diagnosis and one hour if sepsis is suspected.
BioMarin’s Brineura made available on NHS
The £500,000 per patient drug was deemed too costly for use in February 2018.
FDA approves Nucala
The treatment was also recently made available in two new formulations in the UK, a pre-filled pen and a pre-filled syringe.
Ipsen opens new Milton Park research centre
The centre will enable scientists to “better support the development of current and future biological medicines.”
‘Collaborative vision’ could speed up access to medicines
Currently less than 50% of orphan medicines are routinely funded in England, Scotland and Wales.
First patient dosed in Fabry Disease gene therapy trial
The study is the first clinical-stage adeno-associated virus (AAV) gene therapy study globally for Fabry Disease.
Seven new data hubs to be rolled out across UK
The hubs will be the home of “cutting-edge research” for health discoveries.
